Related Experiment Video
Updated: Oct 13, 2025
14:57
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
9.7K
TP53 in Myelodysplastic Syndromes.
Yan Jiang1,2, Su-Jun Gao1, Benoit Soubise2
1Department of Hematology, The First Hospital of Jilin University, Changchun 130021, China.
Cancers
|November 13, 2021
Summary
TP53 mutations significantly impact myelodysplastic syndromes (MDS) prognosis and treatment resistance. Understanding these genetic variants is crucial for improving patient outcomes and developing targeted therapies for MDS.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Myelodysplastic syndromes (MDS) exhibit significant heterogeneity in clinical presentation, prognosis, and progression to acute myeloid leukemia.
- Current prognostic scoring systems (e.g., IPSS, WHO) do not fully account for genetic factors influencing MDS outcomes.
- TP53 mutations are increasingly recognized as a critical factor in MDS, associated with poor prognosis and treatment resistance.
Purpose of the Study:
- To review the characteristics of monoallelic and biallelic TP53 mutations in MDS.
- To explore the carcinogenic mechanisms and prognostic implications of TP53 mutations.
- To evaluate the predictive value of TP53 mutations in response to standard MDS therapies and discuss novel therapeutic strategies.
Main Methods:
- Literature review and analysis of existing clinical trial data.
- Discussion of molecular mechanisms underlying TP53 mutation-associated MDS.
- Synthesis of information on TP53 mutation impact on treatment response.
Main Results:
- TP53 mutations, both monoallelic and biallelic, are independently linked to higher-risk MDS categories.
- These mutations correlate with resistance to conventional therapies like hypomethylating agents and lenalidomide.
- TP53 mutations predict rapid transformation to acute myeloid leukemia and overall poor survival.
Conclusions:
- TP53 mutation status is a vital prognostic biomarker in MDS, necessitating its integration into risk stratification.
- Targeted therapies addressing TP53 dysfunction hold promise for improving outcomes in a subset of MDS patients.
- Further research and clinical trials are essential to optimize TP53-targeted treatment strategies in MDS.
Related Concept Videos
02:23Abnormal Proliferation
4.7K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
02:37DNA Damage can Stall the Cell Cycle
9.5K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.5K
01:23Negative Regulator Molecules
36.5K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.5K
01:12Loss of Tumor Suppressor Gene Functions
5.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.2K
01:31The Intrinsic Apoptotic Pathway
7.0K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.0K
02:17Microtubule Instability
5.4K
Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated...
5.4K